These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8831265)

  • 1. [Crystal forms, improvements of dissolution and absorption of poorly water-soluble (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1, 4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022)].
    Yano K; Takamatsu N; Yamazaki S; Sako K; Nagura S; Tomizawa S; Shimaya J; Yamamoto K
    Yakugaku Zasshi; 1996 Aug; 116(8):639-46. PubMed ID: 8831265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro stability and in vivo absorption studies of colloidal particles formed from a solid dispersion system.
    Yano K; Kajiyama A; Yamazaki S; Matsumura Y; Watanabe K; Yamamoto K
    Chem Pharm Bull (Tokyo); 1996 Dec; 44(12):2309-13. PubMed ID: 8996862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea]: an irreversible cholecystokinin type-B receptor antagonist.
    Dunlop J; Brammer N; Evans N; Ennis C
    Biochem Pharmacol; 1997 Jul; 54(1):81-5. PubMed ID: 9296353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
    Nishida A; Miyata K; Tsutsumi R; Yuki H; Akuzawa S; Kobayashi A; Kamato T; Ito H; Yamano M; Katuyama Y
    J Pharmacol Exp Ther; 1994 May; 269(2):725-31. PubMed ID: 7910212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of dissolution and oral absorption of ER-34122, a poorly water-soluble dual 5-lipoxygenase/cyclooxygenase inhibitor with anti-inflammatory activity by preparing solid dispersion.
    Kushida I; Ichikawa M; Asakawa N
    J Pharm Sci; 2002 Jan; 91(1):258-66. PubMed ID: 11782915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New 1,4-benzodiazepin-2-one derivatives as gastrin/cholecystokinin-B antagonists.
    Satoh M; Kondoh Y; Okamoto Y; Nishida A; Miyata K; Ohta M; Mase T; Murase K
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2159-67. PubMed ID: 8582018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterization of spray-dried phenylbutazone polymorphs.
    Matsuda Y; Kawaguchi S; Kobayashi H; Nishijo J
    J Pharm Sci; 1984 Feb; 73(2):173-9. PubMed ID: 6707878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on Enhanced Dissolution of Azilsartan-Loaded Solid Dispersion, Prepared by Combining Wet Milling and Spray-Drying Technologies.
    Lu T; Sun Y; Ding D; Zhang Q; Fan R; He Z; Wang J
    AAPS PharmSciTech; 2017 Feb; 18(2):473-480. PubMed ID: 27116201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic in vitro and in vivo evaluation for determining the feasibility of making an amorphous solid dispersion of a B-Raf (rapidly accelerated fibrosarcoma) inhibitor.
    Cui Y; Chiang PC; Choo EF; Boggs J; Rudolph J; Grina J; Wenglowsky S; Ran Y
    Int J Pharm; 2013 Sep; 454(1):241-8. PubMed ID: 23834830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution: pros and cons.
    Chokshi RJ; Zia H; Sandhu HK; Shah NH; Malick WA
    Drug Deliv; 2007 Jan; 14(1):33-45. PubMed ID: 17107929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral absorption improvement of poorly soluble drug using solid dispersion technique.
    Kai T; Akiyama Y; Nomura S; Sato M
    Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):568-71. PubMed ID: 8882454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R; Taheri A; Homayouni A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying.
    Yonemochi E; Kitahara S; Maeda S; Yamamura S; Oguchi T; Yamamoto K
    Eur J Pharm Sci; 1999 Mar; 7(4):331-8. PubMed ID: 9971917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
    Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of YM022: its CCKB/gastrin receptor binding profile and antagonism to CCK-8-induced Ca2+ mobilization.
    Saita Y; Yazawa H; Honma Y; Nishida A; Miyata K; Honda K
    Eur J Pharmacol; 1994 Oct; 269(2):249-54. PubMed ID: 7851501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct contractile effect of cholecystokinin octapeptide on caecal circular smooth muscle cells of guinea pig via both CCK-A and CCK-B/gastrin receptors.
    Motomura Y; Chijiiwa Y; Iwakiri Y; Nawata H
    Life Sci; 1997; 60(7):499-504. PubMed ID: 9042379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aging on crystallization, dissolution and absorption characteristics of amorphous tolbutamide-2-hydroxypropyl-beta-cyclodextrin complex.
    Kimura K; Hirayama F; Arima H; Uekama K
    Chem Pharm Bull (Tokyo); 2000 May; 48(5):646-50. PubMed ID: 10823700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.